82822:HK:HK-CSOP FTSE China A50 (CNY)

ETF | Others |

Last Closing

USD 10.25

Change

+0.04 (+0.39)%

Market Cap

USD 7.65B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.44 (+2.13%)

USD 146.84B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+1.76 (+2.34%)

USD 24.81B
2823:HK iShares FTSE A50 China

+0.55 (+3.85%)

USD 21.23B
2801:HK iShares Core MSCI China ETF

+0.50 (+2.31%)

USD 20.56B
83188:HK ChinaAMC CSI 300 Index ETF

+1.68 (+4.05%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

+0.03 (+2.27%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.21 (+2.18%)

USD 9.22B
9010:HK iShares Core MSCI AC Asia ex J..

+0.01 (+0.13%)

USD 3.03B
9846:HK iShares Core CSI 300

+0.11 (+2.81%)

USD 2.96B

ETFs Containing 82822:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.58% 65% D 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.58% 63% D 66% D+
Trailing 12 Months  
Capital Gain -12.24% 51% F 58% F
Dividend Return 2.91% 38% F 28% F
Total Return -9.33% 55% F 59% D-
Trailing 5 Years  
Capital Gain -24.19% 29% F 66% D+
Dividend Return 9.17% 74% C 31% F
Total Return -15.01% 45% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain -4.03% 55% F 51% F
Dividend Return -1.95% 59% D- 52% F
Total Return 2.09% 65% D 41% F
Risk Return Profile  
Volatility (Standard Deviation) 16.48% 55% F 79% B-
Risk Adjusted Return -11.82% 61% D- 50% F
Market Capitalization 7.65B 73% C 83% B

Annual Financials (CNY)

Quarterly Financials (CNY)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike